| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000004944 |
| Receipt No. | R000005885 |
| Official scientific title of the study | comparison of pitavastatin versus EPA on lipid-lowering effect in patients with dyslipidemia |
| Date of disclosure of the study information | 2011/01/25 |
| Last modified on | 2018/08/01 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | comparison of pitavastatin versus EPA on lipid-lowering effect in patients with dyslipidemia | |
| Title of the study (Brief title) | comparison of pitavastatin versus EPA in patients with dyslipidemia | |
| Region |
|
|
| Condition | |||
| Condition | dyslipidemia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | comparison of pitavastatin 2mg/day alone versus EPA 1800mg/day alone on lipid-lowering effect in dyslipidemic patients |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | comparison of changes of LOX-1 ligand density and MT1-MMP expression rate |
| Key secondary outcomes | comparison of change or %change of TC, TG, HDL-C, LDL-C, hs-CRP, sLOX-1 density and the fatty acid compartment |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Pitavastatin 2 mg/day for 6 months | |
| Interventions/Control_2 | EPA 1800 mg/day for 6 months | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1,Dyslipidemic patients whose serum LDL-C levels are more than 140 mg/dL or TC levels are more than 220 mg/dL
2,Patients who provided written informed consent. The study protocol was approved by the Ethics Committee of Fukui University. |
|||
| Key exclusion criteria | 1,pregnant, breast feeding, or could be pregnant
2,severe liver diseases 3,severe kidney diseases (eGFR<30 mL/min/1.73m2) 4,history of allergic reaction to Pitavastatin or EPA 5,Physician does not agree to join the trial |
|||
| Target sample size | 70 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroyasu Uzui |
| Organization | University of Fukui Faculty of Medical Sciences |
| Division name | Division of cardiovascular Medicine |
| Address | 23-3 Shimoaizuki, Eiheiji-cho, Fukui 910-1193, Japan. |
| TEL | 0776-61-3111 |
| huzui@u-fukui.ac.jp | |
| Public contact | |
| Name of contact person | Hiroyasu Uzui |
| Organization | University of Fukui Faculty of Medical Sciences |
| Division name | Division of cardiovascular Medicine |
| Address | 23-3 Shimoaizuki, Eiheiji-cho, Fukui 910-1193, Japan. |
| TEL | 0776-61-3111 |
| Homepage URL | |
| huzui@u-fukui.ac.jp | |
| Sponsor | |
| Institute | University of Fukui Faculty of Medical Sciences, Division of cardiovascular Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Kanazawa Medical University Hospital The 21st Century Multidisciplinary Medical Center |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 福井大学医学部附属病院(福井県)、金沢医科大学病院(石川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000005885 |